
NYSE:BTI
This summary was created by AI, based on 2 opinions in the last 12 months.
British American Tobacco (BTI-N) has experienced a significant uptick in its stock performance, though experts suggest it may have peaked for the time being, particularly in light of ESG concerns. The company recently announced organic revenue growth expectations at the upper end of its guidance range, indicating slight improvement, while maintaining conservative estimates for operating profit. As competition heats up and consumer preferences shift, ongoing investment in R&D for next-generation products is crucial, supported by a recovery in traditional cigarette revenue in the U.S. Despite these positive signals, experts caution that the stock's impressive one-year gain of 72% may not be sustainable, recommending that investors consider reducing their holdings while still benefitting from the attractive dividend yield of 5.01%. Overall, while BAT remains a solid choice for income, the long-term outlook carries certain risks, and maintaining a cautious stance may be advisable.
A clear mean-reversion trade. Historically, it traded between 4.4-6.8. With its 9% yield, you only have to wait 8 years, and then every dollar earned is playing with the house's money. In a recession, income is a scarce commodity. Probably a buyback next year. Transitioning to consumables. You may not like its product, but it's good downside protection. Yield is 9.14%.
(Analysts’ price target is $44.94)
Pays a 9.5% dividend, so over 10 years, you've returned 95% of your capital, assuming no dividend cut. But there is a huge ESG overhang in this sector; everybody hates tobacco stocks. Debt is paid down and the balance sheet is fine, so there's no real risk. The company is transitioning away from burning cigarettes.